12,630 Shares in Omega Healthcare Investors, Inc. (NYSE:OHI) Acquired by Quest Partners LLC

Quest Partners LLC purchased a new stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 12,630 shares of the real estate investment trust's stock, valued at approximately $514,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Daiwa Securities Group Inc. lifted its holdings in shares of Omega Healthcare Investors by 1,030.8% during the 2nd quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust's stock valued at $32,384,000 after acquiring an additional 861,907 shares in the last quarter. Marshall Wace LLP acquired a new position in shares of Omega Healthcare Investors during the second quarter worth about $20,962,000. BROOKFIELD Corp ON purchased a new stake in shares of Omega Healthcare Investors in the first quarter worth about $16,446,000. Dimensional Fund Advisors LP grew its stake in shares of Omega Healthcare Investors by 7.9% in the second quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust's stock valued at $127,831,000 after buying an additional 272,299 shares in the last quarter. Finally, Sei Investments Co. raised its holdings in shares of Omega Healthcare Investors by 150.8% during the 2nd quarter. Sei Investments Co. now owns 298,761 shares of the real estate investment trust's stock valued at $10,233,000 after buying an additional 179,623 shares during the period. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have weighed in on OHI shares. Wells Fargo & Company restated an "overweight" rating and issued a $43.00 price target (up previously from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Scotiabank lifted their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "sector perform" rating in a research note on Monday, August 26th. Royal Bank of Canada upped their price objective on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a "sector perform" rating in a research report on Monday, November 11th. Berenberg Bank started coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They set a "buy" rating and a $45.00 target price on the stock. Finally, BNP Paribas upgraded Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 price target on the stock in a research note on Thursday, October 31st. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $40.00.

Insider Transactions at Omega Healthcare Investors

In related news, CFO Robert O. Stephenson sold 22,542 shares of the firm's stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares of the company's stock, valued at approximately $7,357,824.44. This trade represents a 10.96 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of the company's stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares of the company's stock, valued at approximately $4,025,000. The trade was a 36.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.37% of the company's stock.

Omega Healthcare Investors Stock Down 0.1 %

NYSE OHI traded down $0.03 on Friday, hitting $40.11. 1,745,104 shares of the stock traded hands, compared to its average volume of 2,025,181. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. The stock has a 50-day moving average of $40.62 and a 200 day moving average of $37.01. Omega Healthcare Investors, Inc. has a twelve month low of $27.53 and a twelve month high of $44.42. The company has a market capitalization of $10.83 billion, a P/E ratio of 29.49, a price-to-earnings-growth ratio of 1.25 and a beta of 0.99.

Omega Healthcare Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were issued a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.68%. Omega Healthcare Investors's dividend payout ratio (DPR) is 197.06%.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.